� Health Canada is warning consumers not to use Rize 2 The Occasion capsules (Rize2), an unauthorized product promoted for the treatment of erectile dysfunction, because it crataegus oxycantha pose good health risks. Rize 2 contains an undeclared pharmaceutical ingredient like to the prescription drug sildenafil which should only be used under the supervision of a wellness care professional. The product may pose serious health risks, especially for patients with preexistent medical conditions such as heart problems, those world Health Organization may be taking heart medications, or those world Health Organization may be at risk for strokes.
Use of sildenafil by patients with heart disease can termination in dangerous cardiovascular side-effects such as sudden cardiac death, nerve attack, stroke, low blood pressure, chest pain and abnormal trice. Additionally, use of sildenafil citrate may be associated with other side-effects including vision loss, seizures, sudden decrement or loss of hearing, dizziness, extended erections, headaches, flushing, os nasale congestion, dyspepsia and abdominal muscle pain. Sildenafil should not be used by individuals taking whatever type of nitrate drug (e.g., nitroglycerin) due to the risk of developing potentially life-threatening low blood pressure.
The distributor, Cana International Distributing, is conducting a voluntary recall of all lots of Rize 2 that ar available at retail outlets across Canada and over the Internet. Health Canada advises retailers to remove this production from their shelves, and consumers should return the product to the space of purchase. Canadians world Health Organization have used Rize 2 and ar concerned around their health should consult with a health guardianship professional. Health Canada is taking steps to confirm that the product has been distant from the Canadian market.
In accession to Rize 2, Health Canada advises consumers not to use any unauthorized erectile dysfunction products, and recommends that consumers talk to a health upkeep professional about authorized treatments for cavernous dysfunction.
Health Canada
Health Canada is too reminding consumers to be cautious regarding the purchase of health products over the Internet or from outside of Canada, as these products may not have been assessed to the same standards as products sanctioned for sale on the Canadian marketplace.
Authorized health products testament bear either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN), or a Homeopathic Medicine Number (DIN-HM). This authorization indicates that the products have been assessed by Health Canada for safety, effectiveness and quality.
To reputation a suspected adverse reaction to this health product, please contact the Canada Vigilance Program of Health Canada by one of the next methods:
Telephone: 1-866-234-2345
Facsimile: 1-866-678-6789
Canada Vigilance Program
Marketed Health Products Directorate
Ottawa, Ontario, AL 0701C
K1A 0K9
E-mail: CanadaVigilance@hc-sc.gc.ca
The Canada Vigilance adverse reaction reporting form, including a version that can be completed and submitted on-line, is placed in the MedEffect Canada area of the Health Canada Web site.
More info
